This is to inform that due to some circumstances beyond the organizer control, "3rd Edition of International Precision Medicine Conference" (IPMC 2023) scheduled during April 24-26, 2023 in Orlando, Florida, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at email@example.com or call + 1 (702) 988 2320.
A good drug target is one that is relevant to the disease phenotype and may be modulated therapeutically. The identification and early validation of disease-modifying targets, known as target discovery, is an important first stage in the drug discovery process. Indeed, the completion of the human genome project has fueled interest in determining protein function in both academia and industry. Individualized pharmaceutical therapy tries to produce predictable and optimal therapeutic responses in specific patients. To do so, production platforms and technology that can personalize products to individual patient needs are required.